A Phase 2 Study to Investigate the Safety and Efficacy of ABBV-105 and Upadacitinib Given Alone or in Combination (ABBV-599 Combination) in Subjects with Moderately to Severely Active Systemic Lupus Erythematosus

Project: Research

Project Details

StatusActive
Effective start/end date30/01/20 → 29/01/25

Keywords

  • clinical trial
  • phase 2 study
  • systemic lupus erythematosus (SLE)
  • treatment efficacy